ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and ...

SOLANA BEACH, CA / ACCESS Newswire / April 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the ...

ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint

Combined clearance of the navigation and drug delivery technologies enables Canadian neurosurgery centers to leverage the Company's flagship image-guidance workflow and advances ClearPoint Neuro's ...
Seeking Alpha

ClearPoint Neuro: Solid Progress Still Not Reflected In The Share Price

ClearPoint Neuro's business continues to perform well despite the stock struggling. The drug delivery business is thriving, which should be aided by maturing partner programs and the introduction of ...
Benzinga.com

ClearPoint Neuro Reports Q1 Earnings: Revenue Beat, EPS Miss, Company Affirms FY25 Guidance

ClearPoint Neuro reported total operating expenses of $11.3 million in the quarter. The company ended the period with $12.4 million in cash and cash equivalents. “Our 2025 fiscal year is off to a ...
Seeking Alpha

ClearPoint Neuro: Consumables Growth Is Promising

ClearPoint's fundamentals remain strong, despite recent stock weakness. Consumables growth and an expectation of 15-20 system placements in 2025 are illustrative of this strength. The introduction of ...
Pharmabiz

ClearPoint Neuro receives Canadian nod for its Neuro Navigation System; expands drug delivery ecosystem & global footprint

ClearPoint Neuro receives Canadian nod for its Neuro Navigation System; expands drug delivery ecosystem & global footprint: Solana Beach, California Friday, April 24, 2026, 14:00 ...

Clearpoint Agency Supports American Marketing Association San Diego's 2026 Sandie Awards

Clearpoint Agency, a San Diego and Boston-based award-winning public relations and marketing communications firm, announced its support for the American Marketing Association (AMA) San Diego Chapter's ...
Insider Monkey

Here’s What Boosted ClearPoint Neuro (CLPT) in Q3

Deep Sail Capital, an investment management company, released its third-quarter investor letter. A copy of the letter can be downloaded here. The fund returned 5.8% net of fees in the third quarter, ...
Nasdaq

ClearPoint Neuro Reports Fourth Quarter and Full Year 2021 Preliminary Revenue Results and Guidance for Full Year 2022 Revenue

“As we close the books on 2021, we reflect on a tremendous year for the Company as we have continued to execute and make progress across our four-pillar growth strategy,” commented Joe Burnett, ...
Benzinga.com

ClearPoint Neuro Shares Are Trading Higher Wednesday: What's Going On?

ClearPoint Neuro Inc. (NASDAQ:CLPT) shares are trading higher Wednesday after the company announced results from a Phase I-II clinical study evaluating its ClearPoint Prism Neuro Laser Therapy System.

ClearPoint Neuro, Inc.: ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug ...

SOLANA BEACH, CA / ACCESS Newswire / April 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brai ...